Clinical trials
Tolerance clinical trials
Below are recruiting tolerance clinical trials, each written for real people, not researchers. We’re tracking 947 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03352193Recruiting
Oral wheat tolerance treatment for children with wheat allergy
This trial tests a supervised “oral tolerance induction” approach, which means giving carefully controlled wheat exposure to try to train the immune system to tolerate wheat. It’s designed for children who have confirmed IgE-mediated wheat allergy, aiming to reduce allergic reactions over time.
AthensAges 2–16 - NCT07675590RecruitingPhase 1
Safety study of TIX100 in healthy volunteers
This study tests a new oral medication called TIX100 in healthy people to see if it is safe and how the body handles it. It is the first step in human testing, so it focuses on safety and side effects.
Chula Vista, CaliforniaAges 18–70 - NCT07377565RecruitingPhase 1
Testing a new diagnostic for celiac disease during endoscopy
This study tests a new medicine called HB-2121 used as a diagnostic tool during an upper endoscopy to help improve detection of celiac disease. It's designed for people who are already scheduled for this procedure and may help doctors see the gut damage caused by celiac more clearly.
Stanford, CaliforniaAges 18 years+ - NCT07677137Recruiting
Testing a nerve stimulator for hard-to-treat chronic cluster headache
This trial tests a device that uses mild electrical pulses to the nerves at the back of the head to prevent cluster headaches. It is designed for people whose headaches have not responded to multiple standard treatments.
Sint-NiklaasAges 22–70 - NCT07676084RecruitingPhase 4
Over-the-counter lubricating eye drops for dry eye
This study tests whether over-the-counter lubricating eye drops can improve dry eye symptoms and eye comfort. It compares the drops to no treatment to see how well they work.
Andover, MassachusettsAges 18 years+ - NCT07604116RecruitingPhase 1
Safety study of SST001 in Parkinson's and MSA patients
This is an early-stage study testing a new experimental medicine called SST001 in people with Parkinson's disease (PD) and multiple system atrophy (MSA), as well as healthy volunteers. The study checks whether SST001 is safe, how the body processes it, and where it goes in the body using imaging scans.
Wuxi, JiangsuAges 40 years+ - NCT07674862Enrolling by invitationPhase 1
Safety study of ETD-001 gel in healthy Chinese adults
This trial tests a new gel called ETD-001 on healthy volunteers to see if it's safe and how the body processes it. If you are a healthy Chinese adult, you might be able to join.
Hangzhou, ZhejiangAges 16–60 - NCT02402660Enrolling by invitationPhase 2
Test ALK-001 for Stargardt disease eye changes and comfort
This Phase 2 study tests how well ALK-001 is tolerated and whether it can slow or improve vision-related changes in people with Stargardt disease. It mainly looks at safety (tolerability) and signs in the eye over about 24 months.
Phoenix, ArizonaAges 8–70 - NCT07401121RecruitingPhase 1
Study of CTx1000 for people with ALS
This trial tests a new drug, CTx1000, for people with ALS. It aims to see if the drug is safe and tolerable, and may offer a new treatment option.
Sydney, New South WalesAges 18–80 - NCT07403552RecruitingPhase 1
Testing a new drug's safety in healthy volunteers
This trial is testing a new drug called NSHO-101 in healthy people to see how the body processes it and if it is safe. It helps researchers learn about the drug before testing it in patients with a condition.
Anaheim, CaliforniaAges 18 years+ - NCT07404033RecruitingPhase 1
Testing a lotion for mild to moderate dandruff rash
This trial tests a new lotion for people with mild to moderate seborrheic dermatitis (a common skin condition causing red, scaly patches on the scalp, face, or chest). The study checks safety and how well the lotion works.
Suzhou, JiangsuAges 18–65 - NCT07407543RecruitingPhase 1
Study of SRN001 in healthy Korean and Caucasian men
This trial tests a new drug called SRN001 in healthy men to see how safe it is and how the body processes it. It may help find the right dose for future studies.
SeoulAges 19–60 - NCT07410598Recruiting
Testing a new way to use deep brain stimulation at home
This study tests a new type of brain stimulation called patterned stimulation for people with Parkinson's who already have a deep brain stimulation (DBS) device. It aims to see if using this special stimulation at home is safe and comfortable.
Gainesville, FloridaAges 18–80 - NCT07410637Recruiting
Thyroid hormones and energy in graves' or thyroid cancer
This trial studies how thyroid hormone levels affect your body's use of sugar and energy. It may help people newly diagnosed with Graves' disease or thyroid cancer understand their metabolism better.
Ulm, Baden-WurttembergAges Any age - NCT07412132RecruitingPhase 3
Testing lacosamide for hard-to-treat bipolar depression
This study tests if a medication called lacosamide can help people with bipolar depression that has not improved with at least two other treatments. It's for those with moderate to severe depression in bipolar I or II.
São Paulo, São PauloAges 18–65 - NCT07412353RecruitingPhase 1
Testing safety of single dose SYH2085 in healthy people
This study tests a single dose of an investigational drug called SYH2085 in healthy volunteers to check for side effects, how the body processes the drug, and what happens at different doses. If you qualify, you will help doctors understand if the drug is safe before testing it in patients.
Shanghai, Shanghai MunicipalityAges 18–45 - NCT07417124RecruitingPhase 1
Safety of SNS851 in healthy volunteers
This early-phase trial tests a new investigational drug called SNS851 in healthy volunteers to see if it is safe and how the body handles it. It is a first step in understanding this treatment before testing it in people with a disease.
MelbourneAges 18–55 - NCT07419243RecruitingPhase 1/Phase 2
Tolerance in milk and egg allergy in children
This study watches how milk and egg allergies change naturally over time or after oral immunotherapy (OIT) in children. It helps researchers understand how the immune system adapts, aiming to improve treatment for food allergies.
Madrid, MadridAges 4–17 - NCT07419698RecruitingPhase 1
Safety study of JMT206 injection in healthy volunteers
This early-stage trial tests a new medicine called JMT206 in healthy people to see if it is safe and how the body handles it. Healthy volunteers, ages 18 to 60, are needed to help researchers learn about the drug's effects and how it moves through the body.
Beijing, Beijing MunicipalityAges 18–60 - NCT07420985RecruitingPhase 2
Ingavirin forte for flu and other viral infections
This trial tests different doses of Ingavirin Forte capsules for treating influenza and other respiratory viruses. It may help people with fever, cough, sore throat, and body aches who have been sick less than 48 hours.
IvanovoAges 18–65 - NCT07422207RecruitingPhase 1
Safety study of ME3241 in healthy adults
This trial is testing a new intravenous medicine (ME3241) for safety and how the body handles it. It's for healthy adults, so researchers can see how the drug works before testing it in people with the target condition.
Sydney, New South WalesAges 18–55 - NCT07433192Recruiting
A study on luseogliflozin for type 2 diabetes
This trial is looking at how well a diabetes medicine called luseogliflozin works and how tolerable it is for people with type 2 diabetes. It includes patients who have already started taking the drug as part of their regular care.
AnapaAges 18 years+ - NCT07433335RecruitingPhase 1
First study of sr-878 for rheumatoid arthritis safety
This study tests a new investigational drug called SR-878 for people with rheumatoid arthritis. It aims to see if the drug is safe and tolerable. You may join if you are between 18 and 60, have RA for at least 3 months, and take a stable dose of methotrexate.
TbilisiAges 18–60 - NCT07433556RecruitingPhase 1
Testing a new stomach acid drug in healthy adults
This phase 1 trial tests a new medicine called IY-828026 in healthy volunteers to see how safe it is and how the body processes it. It's a first step to find the right dose and check for side effects.
SeoulAges 19–50
Hear when a new Tolerance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for tolerance?
- Yes. Clin2 currently lists 947 recruiting tolerance studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a tolerance trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a tolerance trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.